[ Price : $8.95]
A PhRMA-funded study says drug companies are not retaining much of the increased drug spending in the U.S.[ Price : $8.95]
FDA clears a Penumbra 510(k) for an expanded indication for its Indigo Aspiration System treating pulmonary embolisms.[ Price : $8.95]
Federal Register notice: FDA announces a 3/27 public meeting entitled Modernizing FDAs Data Strategy.[ Price : $8.95]
Federal Register notice: FDA extends until 1/24 the comment period for a draft guidance entitled Certificates of Confidentiality; ...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension on Focus Groups as Used by the Food and Drug Ad...[ Price : $8.95]
Federal Register notice: FDA extends until 3/23 the comment period on a revised draft guidance entitled Drug Products Labeled as H...[ Price : $8.95]
Blueprint Medicines begins a rolling NDA submission for pralsetinib after reporting top-line data from a pralsetinib study in pati...[ Price : $8.95]
Recipharm staffers discuss the advantages of a quality by design approach to drug manufacturing.